Hippocampal dysfunction in cured Cushing's syndrome patients, detected by 1H‐MR‐spectroscopy
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Summary: Background: Proton magnetic resonance spectroscopy (1H‐MRS) is a sensitive, noninvasive imaging technique capable of measuring brain metabolites in vivo. Chronic exposure to endogenous hypercortisolism in C ushing's syndrome (CS) is associated with negative effects on memory and hippocampal volumes, even after biochemical cure. Objective: To investigate metabolites in the hippocampi of CS patients and controls, using 1H‐MRS. Patients and methods: Eighteen right‐handed cured CS patients (age 44·8 ± 12·5 years, 12·6 ± 3·8 years of education) and 18 right‐handed healthy controls, matched for age (40·0 ± 11·9) and years of education (14·4 ± 3·8), underwent 3‐Tesla magnetic resonance imaging (3 T MRI) and 1H‐MRS including the head of each hippocampus. Concentrations of G lu (G lutamate), G lx (G lutamate + G lutamine), NAA (N‐A cetyl‐aspartate), total NAA (N‐A cetyl‐aspartate + N‐A cetyl‐aspartyl‐G lutamate), C ho (G lycerophosphocholine and P hosphocholine compounds), C r (C reatine) and MI (mionositol) were measured (mmol/l). Hippocampal volumes (mm 3) were additionally calculated using an automated procedure (F ree S urfer). Results: CS patients had lower NAA than controls in the left and right hippocampus (5·2 ± 1·0 vs 6·1 ± 0·7, P < 0·05; 4·9 ± 0·8 vs 6·1 ± 0·6, P < 0·001, respectively), and lower total NAA on the right side (5·7 ± 0·9 vs 6·3 ± 0·9, P < 0·05), suggesting neuronal dysfunction/loss. CS patients had higher G lx than controls in both hippocampi (10·4 ± 1·9 vs 8·6 ± 1·4, P < 0·01; 9·9 ± 1·6 vs 8·9 ± 1·3, P < 0·05, respectively), suggesting glial proliferation, as a repair mechanism after neuronal dysfunction. No differences were found in the other brain metabolites, and there were no differences in left (3815·78 ± 502·96) and right (3980·75 ± 369·44) total hippocampal volumes between CS patients and controls (3945·08 ± 408·90 and 4108·39 ± 365·11, respectively). Conclusion: Persistently abnormal metabolites are evidenced in the hippocampi of CS patients despite endocrine cure. These functional alterations could be early markers of glucocorticoid neurotoxicity, preceding hippocampal volume reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429
Joëls, M., & Baram, T. Z. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2632 · Cited by 1,521
Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212
Hippocampal damage associated with prolonged glucocorticoid exposure in primates
Sapolsky, R., Uno, H., Rebert, C., & Finch, C. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02897.1990 · Cited by 1,103
Jack, C. R., Twomey, C. K., Zinsmeister, A. R., Sharbrough, F. W., Petersen, R. C., & Cascino, G. D. (1989) · Radiology · doi:10.1148/radiology.172.2.2748838 · Cited by 592
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes
Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., Tsui, W., Richardson, S., Javier, E., & Convit, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0602-7 · Cited by 489
Chronic stress: Implications for neuronal morphology, function and neurogenesis
Joëls, M., Karst, H., Krugers, H. J., & Lucassen, P. J. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.04.001 · Cited by 381
Kaiser, L. G., Schuff, N., Cashdollar, N., & Weiner, M. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.001 · Cited by 251
Popovic, V., Pekic, S., Pavlovic, D., Maric, N., Jasovic-Gasic, M., Djurovic, B., Medic-Stojanoska, M., Zivkovic, V., Stojanovic, M., Doknic, M., et al. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345308 · Cited by 195
Subtle cognitive impairments in patients with long-term cure of Cushing’s disease
Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2032 · Cited by 159
Cited by
Andela, C. D., van Haalen, F. M., Ragnarsson, O., Papakokkinou, E., Johannsson, G., Santos, A., Webb, S. M., Biermasz, N. R., van der Wee, N. J. A., & Pereira, A. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1101 · Cited by 164
Self-citationLong-term effects of glucocorticoid excess on the brain
Dekkers, A. J., Amaya, J. M., van der Meulen, M., Biermasz, N. R., Meijer, O. C., & Pereira, A. M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13142 · Cited by 56
“neuron density and impaired compensatory remodulation by micro glial cells or astrocytes.(31) In addition, lower NAA and glutamate in the ventromedial PFC were found in patients with active CS and CS in remission.”
BackgroundLong-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Reduced DNA methylation of FKBP5 in Cushing’s syndrome
Resmini, E., Santos, A., Aulinas, A., Webb, S. M., Vives-Gilabert, Y., Cox, O., Wand, G., & Lee, R. S. (2016) · Endocrine · doi:10.1007/s12020-016-1083-6 · Cited by 42
“of both hippocampi of CS patients, despite endocrine cure of hypercortisolism [13].”
BackgroundSelf-citation
Metadata
- Authors
- Resmini, E., Santos, A., Gómez‐Anson, B., López‐Mourelo, O., Pires, P., Vives‐Gilabert, Y., Crespo, I., Portella, M. J., de Juan‐Delago, M., & Webb, S. M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2013-05-27
- Volume
- 79
- Issue
- 5
- Pages
- 700-707
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2045248125
- Cited by
- 48
- References
- 11
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.